- Home
- TLSA vs TNYA Comparison
TLSA vs TNYA Comparison
Compare TLSA & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- TNYA
- Stock Information
- Founded
- TLSA 2013
- TNYA 2016
- Country
- TLSA United Kingdom
- TNYA United States
- Employees
- TLSA N/A
- TNYA N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- TLSA Health Care
- TNYA Health Care
- Exchange
- TLSA Nasdaq
- TNYA Nasdaq
- Market Cap
- TLSA 87.8M
- TNYA 74.5M
- IPO Year
- TLSA 2000
- TNYA 2021
- Fundamental
- Price
- TLSA $1.57
- TNYA $0.41
- Analyst Decision
- TLSA
- TNYA Strong Buy
- Analyst Count
- TLSA 0
- TNYA 6
- Target Price
- TLSA N/A
- TNYA $8.60
- AVG Volume (30 Days)
- TLSA 460.2K
- TNYA 1.8M
- Earning Date
- TLSA 05-20-2025
- TNYA 05-07-2025
- Dividend Yield
- TLSA N/A
- TNYA N/A
- EPS Growth
- TLSA N/A
- TNYA N/A
- EPS
- TLSA N/A
- TNYA N/A
- Revenue
- TLSA N/A
- TNYA N/A
- Revenue This Year
- TLSA N/A
- TNYA N/A
- Revenue Next Year
- TLSA N/A
- TNYA N/A
- P/E Ratio
- TLSA N/A
- TNYA N/A
- Revenue Growth
- TLSA N/A
- TNYA N/A
- 52 Week Low
- TLSA $0.54
- TNYA $0.39
- 52 Week High
- TLSA $1.91
- TNYA $4.78
- Technical
- Relative Strength Index (RSI)
- TLSA 64.57
- TNYA 34.79
- Support Level
- TLSA $1.49
- TNYA $0.45
- Resistance Level
- TLSA $1.78
- TNYA $0.53
- Average True Range (ATR)
- TLSA 0.18
- TNYA 0.04
- MACD
- TLSA 0.04
- TNYA 0.00
- Stochastic Oscillator
- TLSA 71.23
- TNYA 15.35
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.